The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Abstract
Pseudomonas aeruginosa lung infection is an important cause of morbidity and mortality in cystic fibrosis (CF). Longitudinal assessment of the phenotypic changes in P. aeruginosa isolated from young children with CF is lacking. This study investigated genotypic and phenotypic changes in P. aeruginosa from oropharynx (OP) and bronchoalveolar lavage fluid (BALF) in a cohort of 40 CF patients during the first 3 years of life; antibody response was also examined. A high degree of genotypic variability was identified, and each patient had unique genotypes. Early isolates had a phenotype distinct from those of usual CF isolates: generally nonmucoid and antibiotic susceptible. Genotype and phenotype correlated between OP and BALF isolates. As determined by culture, 72.5% of patients demonstrated P. aeruginosa during their first 3 years. On the basis of combined culture and serologic results, 97.5% of patients had evidence of infection by age 3 years, which suggests that P. aeruginosa infection occurs early in CF and may be intermittent or undetectable by culture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Inflammatory cytokines in cystic fibrosis lungs.
Bonfield, T. L., Panuska, J. R., Konstan, M. W., Hilliard, K. A., Hilliard, J. B., Ghnaim, H., & Berger, M. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520783 · Cited by 711
Microbiology of airway disease in patients with cystic fibrosis
Gilligan, P. H. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.1.35 · Cited by 529
Frederiksen, B., Koch, C., & Høiby, N. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o · Cited by 473
Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
ARMSTRONG, D. S., GRIMWOOD, K., CARLIN, J. B., CARZINO, R., GUTIÈRREZ, J. P., HULL, J., OLINSKY, A., PHELAN, E. M., ROBERTSON, C. F., & PHELAN, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., Ramsey, B. W., & Clausen, C. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514631 · Cited by 421
Self-citationLower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
Armstrong, D. S., Grimwood, K., Carzino, R., Carlin, J. B., Olinsky, A., & Phelan, P. D. (1995) · BMJ · doi:10.1136/bmj.310.6994.1571 · Cited by 357
Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients
MUHLEBACH, M. S., STEWART, P. W., LEIGH, M. W., & NOAH, T. L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9808096 · Cited by 354
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Self-citationLung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Self-citationO'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N., & Molin, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2907 · Cited by 715
Lee, T. W. R., Brownlee, K. G., Conway, S. P., Denton, M., & Littlewood, J. M. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00141-8 · Cited by 713
Nadell, C. D., Xavier, J. B., & Foster, K. R. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00150.x · Cited by 667
A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
Balasubramanian, D., Schneper, L., Kumari, H., & Mathee, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1039 · Cited by 591
Human Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01681.x · Cited by 585
Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl
Franklin, M. J., Nivens, D. E., Weadge, J. T., & Howell, P. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00167 · Cited by 576
Pyoverdine siderophores: from biogenesis to biosignificance
Visca, P., Imperi, F., & Lamont, I. L. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2006.11.004 · Cited by 544
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Döring, G., Flume, P., Heijerman, H., & Elborn, J. S. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.10.004 · Cited by 474
The microbiome of the upper respiratory tract in health and disease
Kumpitsch, C., Koskinen, K., Schöpf, V., & Moissl-Eichinger, C. (2019) · BMC Biology · doi:10.1186/s12915-019-0703-z · Cited by 465
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Self-citationMoskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Starkey, M., Hickman, J. H., Ma, L., Zhang, N., De Long, S., Hinz, A., Palacios, S., Manoil, C., Kirisits, M. J., Starner, T. D., et al. (2009) · Journal of Bacteriology · doi:10.1128/jb.00119-09 · Cited by 399
Moskowitz, S. M., Foster, J. M., Emerson, J., & Burns, J. L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1915-1922.2004 · Cited by 397
Self-citationEarly pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis*
Rosenfeld, M., Gibson, R. L., McNamara, S., Emerson, J., Burns, J. L., Castile, R., Hiatt, P., McCoy, K., Wilson, C. B., Inglis, A., et al. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1144 · Cited by 395
Self-citationRamsey, D. M., & Wozniak, D. J. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04552.x · Cited by 391
D'Argenio, D. A., Wu, M., Hoffman, L. R., Kulasekara, H. D., Déziel, E., Smith, E. E., Nguyen, H., Ernst, R. K., Larson Freeman, T. J., Spencer, D. H., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05678.x · Cited by 342
Self-citationTaylor, P. K., Yeung, A. T. Y., & Hancock, R. E. W. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.003 · Cited by 340
Gustafsson, P. M., Aurora, P., & Lindblad, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00049502 · Cited by 326
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
Langton Hewer, S. C., & Smyth, A. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004197.pub4 · Cited by 324
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Self-citationSaiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs
Jorth, P., Staudinger, B. J., Wu, X., Hisert, K. B., Hayden, H., Garudathri, J., Harding, C. L., Radey, M. C., Rezayat, A., Bautista, G., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.07.006 · Cited by 306
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
Hoffman, L. R., Kulasekara, H. D., Emerson, J., Houston, L. S., Burns, J. L., Ramsey, B. W., & Miller, S. I. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.006 · Cited by 301
Self-citationCharacterization of Colony Morphology Variants Isolated from Pseudomonas aeruginosa Biofilms
Kirisits, M. J., Prost, L., Starkey, M., & Parsek, M. R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4809-4821.2005 · Cited by 290
Williamson, K. S., Richards, L. A., Perez-Osorio, A. C., Pitts, B., McInnerney, K., Stewart, P. S., & Franklin, M. J. (2012) · Journal of Bacteriology · doi:10.1128/jb.00022-12 · Cited by 289
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Murphy, T. F., Brauer, A. L., Eschberger, K., Lobbins, P., Grove, L., Cai, X., & Sethi, S. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1413oc · Cited by 280
Sousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
Biofilm Formation As a Response to Ecological Competition
Oliveira, N. M., Martinez-Garcia, E., Xavier, J., Durham, W. M., Kolter, R., Kim, W., & Foster, K. R. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002191 · Cited by 278
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Brady, C., Guill, M., Lahiri, T., Lubsch, L., Matsui, J., Oermann, C. M., Ratjen, F., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-166oc · Cited by 269
Self-citationEnhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils
Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3693-3701.2005 · Cited by 263
Feltner, J. B., Wolter, D. J., Pope, C. E., Groleau, M.-C., Smalley, N. E., Greenberg, E. P., Mayer-Hamblett, N., Burns, J., Déziel, E., Hoffman, L. R., et al. (2016) · mBio · doi:10.1128/mbio.01513-16 · Cited by 265
Self-citationAdaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Hogardt, M., & Heesemann, J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.008 · Cited by 257
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., & Monsó, E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2044-0 · Cited by 136
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis
Sudfeld, C. R., Dasenbrook, E. C., Merz, W. G., Carroll, K. C., & Boyle, M. P. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.11.010 · Cited by 128
Rhodes, J., Beale, M. A., Vanhove, M., Jarvis, J. N., Kannambath, S., Simpson, J. A., Ryan, A., Meintjes, G., Harrison, T. S., Fisher, M. C., et al. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.037499 · Cited by 100
Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03514-14 · Cited by 50
Self-citationPenesyan, A., Kumar, S. S., Kamath, K., Shathili, A. M., Venkatakrishnan, V., Krisp, C., Packer, N. H., Molloy, M. P., & Paulsen, I. T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138527 · Cited by 40
Metadata
- Authors
- Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., & Ramsey, B. W.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02
- Volume
- 183
- Issue
- 3
- Pages
- 444-452
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2166779461
- Cited by
- 555
- References
- 25
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.